A Randomized, Double-Masked, 48-Week, Parallel-Group, Placebo-Controlled, Proof-Of-Concept Study To Investigate The Efficacy And Safety Of Rg7774 In Patients With Diabetes Mellitus Type 1 Or Type 2 With Treatment-Naïve Diabetic Retinopathy.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 135 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | A Randomized, Double-Masked, 48-Week, Parallel-Group, Placebo-Controlled, Proof-of-Concept Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy |
| Actual Study Start Date : | June 5, 2020 |
| Estimated Primary Completion Date : | June 1, 2023 |
| Estimated Study Completion Date : | June 1, 2023 |
